MSc, University of Chicago, 2015
PhD, University of Colorado, 2013
MS, Dartmouth College, 2008
BS, Northwestern University, 2006
William V. Padula, PhD is Assistant Professor of Health Policy and Management at The Johns Hopkins University Bloomberg School of Public Health in Baltimore, MD. His research explores problems in health economics and health services research with several focus areas: (1) the theoretical foundations of medical cost-effectiveness analysis; (2) using data analytics to predict health outcomes; (3) quality improvement and reduced cost of hospital care; and (4) drug pricing issues. He is a member of Hopkins’ Interdepartmental Program in Health Economics and teaches the economic evaluation modeling curriculum. He has performed innovative comparative effectiveness research and cost-effectiveness analysis of quality improvement strategies to prevent hospital-acquired conditions, particularly regarding pressure injury (aka “bedsore”) care. In 2017, he and colleagues collaborated with the Maryland Attorney General to pass bipartisan Maryland State legislation to restrict price hikes on generic pharmaceuticals – the first of its kind in the U.S.
He is jointly appointed in the School of Nursing and the Armstrong Institute for Patient Safety and Quality at Johns Hopkins Medicine. Prior to joining Hopkins, he was a health economics fellow in the Department of Medicine at The University of Chicago and led an AHRQ-funded investigation to develop predictive algorithms of patient risk for developing pressure injuries in hospitals. In addition to over 50 scientific publications and receiving numerous awards, he serves on the Board of Directors for the National Pressure Ulcer Advisory Panel (NPUAP) and as a Commissioner for the American Nurses Credentialing Center (ANCC) Magnet® Recognition Program.
Honors and Awards
Research Award, Best New Investigator, International Society of Pharmacoeconomics & Outcomes Research (ISPOR) European Congress 2016
Young Investigator Award, Society for Advancement in Wound Care (SAWC) 2016
“Top Reviewer” for Annals of Internal Medicine in 2013, 2014, 2015 and 2016
Outstanding Dissertation Award, Honorable Mention, AcademyHealth 2015
Best-in-Show, M.Sc. Analytics Thesis Defense, University of Chicago 2015
Diversity Small Grant Award recipient from University of Chicago Medicine in both Spring and Fall of 2014
Best Abstract, Health Services Research Category by a Fellow, Department of Medicine Research Day, University of Chicago 2014
Select Publications by Research Area
- DRUG PRICING: (A) Green JA and Padula WV. Targeting Unconscionable Prescript-Drug Prices – Maryland’s Anti-Price-Gouging Law. The New England Journal of Medicine, 2017 Jul 13;377(2):101-103. PMID: 28591520. (B) Padula WV, Larson RA, Dusetzina SB, et al. Cost-effectiveness of Tyrosine Kinase Inhibitors Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After U.S. Generic Entry of Imatinib. Journal of the National Cancer Institute (JNCI), 2016 Mar 4;108(7). PMID: 26944912.
- CEA/CER PRESSUR INJURY PREVENTION: (A) Padula WV, Gibbons RD, Valuck RJ, Makic MBF, Mishra MK, Pronovost PJ, Meltzer DO. Are Evidence-based Practices Associated with Effective Prevention of Hospital-acquired Pressure Ulcers in U.S. Academic Medical Centers? Medical Care, 2016 May;54(5):512-8. PMID: 27078824. (B) Padula WV, Mishra MK, Makic MB, Sullivan PW. Improving the Quality of Pressure Ulcer Care with Prevention: a cost-effectiveness analysis. Medical Care, 2011;49(4):385-92. PMID: 21368685
- APPLICATIONS IN ECONOMIC EVALUATION: (A) Padula WV, Phelps CE, Moran D, Earley C. Allocating Provider Resources to Diagnose and Treat Restless Leg Syndrome: A Cost-Utility Analysis. Sleep Medicine, 2017 Jul (In Press). (B) Padula WV, Lee KHC, Pronovost PJ. Using Economic Evaluation to Illustrate Value of Care for Improving Patient Safety & Quality: Choosing the Right Method. Journal of Patient Safety, 2017 Jul (In Press).
- PATIENT-CENTERED OUTCOMES RESEARCH: (A) Padula WV, Millis MA, Worku A, Pronovost PJ, Bridges JFP, Meltzer DO. Individualized Cost-effectiveness Analysis of Patient-centered Care: a case series of hospitalized patient preferences departing from practice-based guidelines. Journal of Medical Economics, 2017 Mar:20(3):288-96. PMID: 27786569. (B) Padula WV, Gibbons RD, Pronovost PJ, Hedeker D, Mishra MK, Makic MBF, Bridges JFP, Wald HL, Valuck RJ, Ginensky AJ, Ursitti A, Venable LR, Epstein Z, Meltzer DO. Using Clinical Data to Predict High-cost, Performance Coding Issues Associated with Pressure Ulcers: a multilevel cohort model. Journal of the American Medical Informatics Association (JAMIA), 2017 Apr;24(e1):e95-e102. PMID: 27539199
- LGBT HEALTHCARE: (A) Padula WV, Heru S, Campbell JD. Societal and policy implications of provider coverage for primary and preventive care in the U.S. transgender population: a cost-effectiveness analysis. Journal of General Internal Medicine (JGIM), 2016 Apr;31(4):394-401. PMID: 26481647. (B) Padula WV, Baker K. Coverage for Gender-Affirming Care: Making Health Insurance Work for Transgender Americans. LGBT Health, 2017 Jul;4(4).PMID:28708447.
See all publications by William V. Padula